Javelin Lung100, Primus, Nintnivo, Impower010: Investigating Io In Nsclc

JAVELIN Lung100, PRIMUS, NintNivo, IMpower010: investigating IO in NSCLC

IMpower010: adjuvant atezolizumab improves DFS in resected stage II-IIIA NSCLC

The importance of the Phase III JAVELIN LUNG 100 trial in non-small-cell lung cancer

The JAVELIN 100 study: a trial to improve lung cancer treatment

IMPower 010: Adjuvant Atezolizumab in NSCLC - OncTalk Lung 2023

GRACE - Global Resource for Advancing Cancer Education

Disease-free survival in IMpower010 trial: adjuvant atezolizumab in NSCLC

KEYNOTE-091 and IMPOWER010: adjuvant chemotherapy for NSCLC

IMpower010 supports adjuvant atezolizumab in early-stage NSCLC | Heather Wakelee

Medicine Matters oncology

What Did We Learn From IMpower010 in Resectable NSCLC? - Medpage Today

IMpower010: OS results of atezolizumab vs best supportive care in resected NSCLC

IMpower010: A Phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...

Dr. Anne Chiang on Molecular Testing in Lung Cancer Treatment Planning

Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial

Lung cancer highlights from ESMO 2022

JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancer

Medicine Matters oncology

Dr. Melissa Johnson on Atezolizumab in Patients With NSCLC

ASCO 2021 Lung Recap: IMpower010: Atezolizumab after Chemo in Non-Small Cell Lung Cancer

GRACE - Global Resource for Advancing Cancer Education

Single Liposome Assay: Detecting Compositional Inhomogeneity-Individual Liposomes l Protocol Preview

JoVE (Journal of Visualized Experiments)

Adjuvant atezolizumab in NSCLC

IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC